AZD0530 (saracatinib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD0530 (saracatinib), covering 2011-05-16 to 2014-02-11. Get the full timeline:
Most recent: Clinical Trial Update: AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]